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Purpose: Ocular surface mucins and glycocalyx are critical for providing ocular hydra-
tion as well lubrication and repelling pathogens or allergens. Elevated levels of tear
proinflammatory cytokines in dry eyemay have detrimental effect onmucins andglyco-
calyx. The present study tested the effect of proinflammatory cytokines IL-6, TNF-α,
and IFN-γ onmembrane-tetheredmucins expression, glycocalyx, and viability of ocular
surface epithelial cells.
Methods: Stratified cultures of human corneal and conjunctival epithelial cells were
exposed to different concentrations of IL-6, TNF-α, and IFN-γ for 24 hours. The mucins
gene and protein expressions were quantified by real-time polymerase chain reaction
(PCR) and enzyme-linked immunosorbent assay (ELISA). The glycocalyx was imaged
using confocalmicroscopy after stainingwith Alexa 488-conjugatedwheat germ agglu-
tinin lectin. Apoptotic and necrotic cell death was quantified using flow cytometry.
Results: IL-6, TNF-α, and IFN-γ treatment resulted in a significant increase in mucins
(MUC)1 and MUC4 gene and protein expression in human corneal epithelial cells but
caused no significant changes in the levels of these mucins in conjunctival epithe-
lial cells. Further, these cytokines decreased MUC16 expression in both corneal and
conjunctival epithelial cells. Moreover, no notable change in glycocalyx or apoptotic
cell death in corneal and conjunctival epithelial cells was noted with any of the tested
cytokines, but IL-6 and TNF-α exposure increased necrotic cell death in corneal and
conjunctival epithelial cells, respectively.
Conclusions:Our results demonstrate that proinflammatory cytokines have differential
effects on human corneal and conjunctival epithelial cell mucins expression, but do not
cause any damage to ocular surface epithelial cell glycocalyx.
Introduction
The apical surface of human corneal and conjunc-
tival epithelial cells is covered with a layer of glyco-
calyx that forms a boundary between these cells and
the tear film.1–3 Glycocalyx is a network made up
of membrane-tethered mucins, their side chains, and
galectin-3.1–7 Glycocalyx and mucins are critical for
ocular health as they serve many functions, includ-
ing repelling pathogens, keeping the ocular surface
hydrated, protecting the cells against mechanical and
chemical damage, as well as reducing friction during
blinking.1–7
Dry eye or keratoconjunctivitis sicca is a common
ocular condition with a high global prevalence. The
disease is characterized by loss of tear film homeosta-
sis, tear hyperosmolarity, ocular surface inflammation,
and neurosensory abnormalities.8,9 Although multi-
ple factors contribute to the pathogenesis of dry eye,
the immune-mediated inflammatory response plays a
central role in its onset and progression.10–14 Hyper-
osmolar stress has been shown to trigger the release
of proinflammatory cytokines IL-1, IL-6, and TNF-
α from ocular surface epithelial cells.15,16 Hyperos-
molar stress due to increased tear osmolarity in dry
eye disease and the associated release of cytokines
can contribute to the early stage of ocular surface
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inflammation. Levels of IL-6 and TNF-α have been
reported to be elevated in the tears of patients suffering
fromdry eye.17 These proinflammatory cytokines along
with chemokines are also responsible for activation,
maturation, and migration of antigen-presenting cells
in the early stages of dry eye disease.10–14 Subsequently,
activated antigen-presenting cells recruit T cells, which
have been shown to secrete IL-17 and IFN-γ .10–14 T
cell-derived cytokines contribute to the amplification
stage of inflammation in dry eye disease.10–14
The promoter region of genes encoding for
mucins have response elements for signaling pathways
activated by proinflammatory cytokines including IL-
6, TNF-α, and IFN-γ suggesting that these cytokines
can modulate the gene expression of mucins.18–21
Additionally, these cytokines have been shown to
induce the expression of enzymes, such as heparanase
and hyaluronidase that may have a detrimental effect
on the glycocalyx.22,23 Immunological and conjunc-
tiva impression cytology studies have shown that the
levels of mucins or the degree of their glycosylation is
notably altered in both the cornea as well as conjunc-
tiva of patients suffering fromnon-Sjogren and Sjogren
syndrome-related dry eye disease.1,2,24 Therefore, the
present study is designed to investigate the effect of
two early-stage (IL-6 and TNF-α) and one amplifi-
cation stage (IFN-γ ) proinflammatory cytokines on
membrane-tethered mucins (MUC) MUC1, MUC4,
MUC16, ocular surface glycocalyx, and cell viabil-
ity of human stratified corneal and human stratified
conjunctival epithelial cells. Because patients suffer-
ing from dry eye have elevated tear levels of these
cytokines in picogram range, the present study tested
the effect of these cytokines on ocular surface mucins
and glycocalyx at the pathologically relevant picogram
concentrations.
Methods
Stratified Human Corneal and Conjunctival
Epithelial Cell Culture
Telomerase-transformed human corneal and
conjunctival epithelial cell lines were used for this
study. Human corneal epithelial cells were propagated
in keratinocyte growth medium supplemented with
bovine pituitary extract (0.004 mL/mL), human
epidermal growth factor (0.125 ng/mL), human
insulin (5 μg/mL), hydrocortisone (0.33 μg/mL),
epinephrine (0.39 μg/mL), transferrin (10 μg/mL),
and calcium chloride (0.15 mM; PromoCell GmbH,
Heidelberg, Germany). To induce stratification, the
cells were plated on a collagen-coated 3.0 μm PTFE
transwell membrane inserts (Corning Inc., Corning,
NY, USA) and the media was switched to supple-
mented keratinocyte growth medium containing a
higher concentration of CaCl2 (1.15 mM). This media
was added both on the inserts as well as the bottom
well until the cells reached 100% confluence. Once the
cells reached 100% confluence, the media was added
to the bottom of the well only, leaving the membrane
inserts containing the cells exposed to air for 1 week to
achieve stratification into a multilayered epithelium.25
The human conjunctival epithelial cells were propa-
gated in keratinocyte serum-free medium supple-
mented with 25 μg/mL bovine pituitary extract,
0.2 ng/mL epidermal growth factor, and 0.4 mM
CaCl2 (Gibco-Invitrogen Corp., Rockville, MD,
USA). Once the cells reached 50% confluence, the
media was switched to a 1:1 mixture of supple-
mented keratinocyte serum-free medium and low-
calcium DMEM without HEPES/F12 media (Gibco-
Invitrogen Corp., Rockville, MD, USA). When the
cells reached 100% confluence, the media was replaced
with DMEM/F12 media supplemented with 1 mM
CaCl2, 10% Calf serum, and 10 ng/mL EGF for about
5 to 7 days to induce stratification.26,27
Cytokine Treatments
The cytokines were purchased from PeproTech
(Cranbury, NJ, USA). To test the effects of proin-
flammatory cytokines onmucin expression, glycocalyx,
and epithelial viability, the stratified cultures of human
corneal and conjunctival epithelial cells were separately
exposed to IL-6, TNF-α, and IFN-γ at five differ-
ent concentrations (30, 60, 125, 250, 500 pg/mL) for
24 hours. Each experiment was conducted in quadru-
plicate.
Isolation of mRNA and Preparation of cDNA
The total RNA from the control and cytokine
exposed stratified corneal and conjunctival epithelial
cells was isolated using a commercially available kit
(Qiagen’s RNeasy Mini Kit, Valencia, CA, USA) as
per the manufacturer’s instructions. The RNA was
immediately reverse transcribed to cDNA using a
commercially available kit (SuperScript III First-Stand;
Invitrogen, Carlsbad, CA, USA).
Mucin Gene Expression Quantification
The gene expression of MUC1, MUC4, and
MUC16 was quantified using real-time polymerase
chain reaction (PCR). A 20 μL reaction mixture
containing 2 μL of cDNA and 18 μL of SYBR Green
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Master Mix was run at a universal cycle (95°C for
10 minutes, 40 cycles at 95°C for 15 seconds, and 55°C
for 60 seconds) using real-time thermocycler (Biorad
CFXThermal Cycler; Bio-Rad Laboratories, Hercules,
CA, USA). β-actin was used as the housekeeping gene.
The relative change in gene expression was calculated
using the Ct method.
Protein Extraction andMucin Enzyme-Linked
Immunosorbent Assays
To prepare protein extracts, control, and cytokine
exposed stratified corneal and conjunctival epithe-
lial cells were incubated for 30 minutes on ice
in radioimmunoprecipitation assay (RIPA) buffer
containing protease inhibitor (Thermo Fisher Scien-
tific, Rockford, IL, USA) on a shaker followed by
the removal of any adherent cells using a cell scraper.
The supernatant was collected as total cell lysate, and
protein concentration was determined by the BCA
method using a commercially available kit (Pierce BCA
Protein Assay Kit; Thermo Fisher Scientific). Protein
levels of MUC1 (Thermo Fisher Scientific), MUC4,
and MUC 16 were quantified in the cell lysate using
commercially available enzyme-linked immunosorbent
assay (ELISA) kits (LifeSpan Biosciences, Inc., Seattle,
WA, USA). For MUC1 and MUC4, 100 μL of
undiluted cell lysate was used. For MUC16, corneal
and conjunctival cell lysates were diluted 4 times and
200 times, respectively.
Glycocalyx Staining
The stratified cultures of control and cytokine-
exposed human corneal and conjunctival epithelial
cells were fixed in 4% paraformaldehyde. The cells
were blocked in 5% BSA for 20 minutes. Glycoca-
lyx was stained using 1.5 μg/mL solution of Alexa
488- conjugated wheat germ agglutinin lectin (Thermo
Fisher Scientific, Hanover Park, IL, USA) for 20
minutes. Wheat germ agglutinin lectin binds to the
N-acetylglucosamine and N-acetylneuraminic acid
residues present on the ocular surface glycocalyx and
has been used in multiple studies, including human
patients to stain corneal glycocalyx.28,29 The stained
glycocalyx was imaged using a confocal microscope
(Nikon Inc., Mellville, NY, USA). Four images were
captured from the randomly selected areas of each
cultured well (total n = 16 for each cytokine because
the experiment was in quadruplicate). The quantifica-
tion of the glycocalyx stained areawas performed using
Image J software in a blinded manner.
Flow Cytometry Quantification of Apoptotic
and Necrotic Cell Death
The stratified cultures of control and cytokine
exposed human corneal and conjunctival epithelial cells
were incubated in the dark at room temperature for
10 minutes in a solution containing 1:2000 propidium
iodide and 1:300FITC-conjugated annexinV (Cayman
Chemical, Ann Harbor, MI, USA). The PI positive
and FITC negative cells were quantified as necrotic.
To calculate apoptotic cells, PI positive FITC negative
cells were subtracted from PI positive + FITC negative
cell population. The populations of stained cells were
analyzed using BD FACSverse flow cytometer (BD
Sciences, San Jose, CA, USA). The data were analyzed
using FlowJo software.
Statistics
The data are presented as mean ± standard error
of mean. Statistical analysis was performed using
GraphPad Prism software (GraphPad Prism, version
8; GraphPad, San Diego, CA, USA). The data were
analyzed using 1-way ANOVA, followed by Dunnett’s
post hoc test. AP value of <0.05 was considered statis-
tically significant.
Results
Effect of IL-6, TNF-α, and IFN-γ on
Membrane-Tethered Mucins Gene and
Protein Expression in Stratified Human
Corneal and Conjunctival Epithelial Cells
To test the effect of IL-6, TNF-α, and IFN-γ on
ocular surface mucins gene expression, the stratified
human corneal and conjunctival epithelial cells were
exposed to five concentrations of these cytokines.
IL-6 treatment caused a significant increase in the
gene expression of MUC1 and MUC4 but caused a
notable decrease in the gene expression of MUC16
in the human corneal epithelial cells (Fig. 1A). For
both MUC1 and MUC4, IL-6 showed a bell-shaped
dose response curve with a less pronounced effect
at 30 pg/mL followed by a dose-dependent signifi-
cant (P < 0.05 compared to control cells not exposed
to IL-6) increase in gene expression at 60, 125, and
250 pg/mL then a subsequent decrease in effect at
500 pg/mL. In congruence with the gene expression
data, IL-6 treatment also caused a significant increase
(P < 0.05 compared to control cells not exposed to
IL-6) in protein levels of MUC1 and MUC4 and a
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Figure 1. Effect of IL-6 onMUC1,MUC4,MUC16 gene, and protein expression in stratified cultures of human corneal (A, B) and conjunctival
(C, D) epithelial cells. The cells were exposed to IL-6 for 24 hours. *P < 0.05 compared to control cells (C) that were not exposed to IL-6.
Figure 2. Effect of TNF-α onMUC1, MUC4, MUC16 gene, and protein expression in stratified cultures of human corneal (A, B) and conjunc-
tival (C, D) epithelial cells. The cells were exposed to TNF-α for 24 hours. *P < 0.05 compared to control cells (C) that were not exposed to
TNF-α.
Downloaded from tvst.arvojournals.org on 06/21/2021
Proinflammatory Cytokines and Mucins TVST | June 2021 | Vol. 10 | No. 7 | Article 17 | 5
Figure 3. Effect of IFN-γ on MUC1, MUC4, and MUC16 gene expression in stratified cultures of human corneal (A, B) and conjunctival
(C, D) epithelial cells. The cells were exposed to IFN-γ for 24 hours. *P < 0.05 compared to control cells (C) that were not exposed to IFN-γ .
significant decrease (P < 0.05 compared to control
cells not exposed to IL-6) in MUC16 in corneal epithe-
lial cells (Fig. 1B). Compared to corneal epithelial
cells, very low levels of MUC1 and MUC4 proteins
were detected in human conjunctival epithelial cells.
Furthermore, IL-6, in contrast to the corneal epithelial
cells, did not significantly change MUC1, MUC4 gene
and protein expression, and MUC16 gene expression
in stratified human conjunctival epithelial cells but it
caused a significant decrease in MUC16 protein levels
(Figs. 1C, 1D).
TNF-α treatment also caused significant (P < 0.05
compared to control cells not exposed to TNF-α)
increase in the gene expression of MUC1 and MUC4
in stratified human corneal epithelial cells but did not
cause any notable change in MUC16 (Fig. 2A). It is
worth noting that the various tested concentrations of
TNF-α caused a similar increase in the gene expres-
sion of MUC1 and MUC4 suggesting that the effect
of TNF-α may not be dose-dependent but a likely
response of all or no pattern. Consistent with the
changes in gene expression, 250 pg/mL dose of TNF-
α caused a significant (P < 0.05 compared to control
cells not exposed to TNF-α) increase in MUC1 and
MUC4 protein levels but this dose also caused a signif-
icant decrease in MUC16 protein levels (Fig. 2B). On
the other hand, TNF-α did not cause any notable
change in MUC1, MUC4 gene and protein expres-
sion, and MUC16 gene expression in the stratified
human conjunctival epithelial cells, However, similar to
the effect observed in corneal epithelial cells, TNF-α
caused a significant decrease inMUC16 protein expres-
sion (Fig. 2D).
Consistent with the effects observed with IL-6 and
TNF-α, IFN-γ exposure also caused a significant
(P < 0.05 compared to control cells not exposed to
IFN-γ ) increase in the both the gene and protein
expression of MUC1 and MUC4 in the stratified
human corneal epithelial cells but did not cause
any change in MUC16 gene and protein expression
(Figs. 3A, 3B). Various doses of IFN-γ also caused
a similar increase in the gene expression of MUC1
and MUC4 suggesting that the effect of IFN-γ is
not dose-dependent but follows all or no response.
Akin to the other two cytokines, IFN-γ also did
not cause any significant change in the gene expres-
sion of MUC1, MUC4, and MUC 16 (Fig. 3C) in
stratified human conjunctival epithelial cells but it
caused a significant decrease in MUC16 protein levels
(Fig. 3D).
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Effect of IL-6, TNF-α, and IFN-γ on Stratified
Human Corneal and Conjunctival Epithelial
Cell Glycocalyx
The integrity of glycocalyx is important for the
barrier, lubrication, and hydration functions of ocular
surface epithelial cells.1,2 Glycocalyx, along with
mucins, contains side-chain structural and chemical
components to form a network.1–7 Proinflammatory
cytokines have been shown to increase enzymes that
can digest these components and damage glycoca-
lyx.22,23 Therefore, we next tested the effect of these
proinflammatory cytokines on human corneal and
conjunctival epithelial cell glycocalyx. Wheat germ
agglutinin lectin binds to the sialic acid residues and
has been previously used to stain the glycocalyx.28,29
Figure 4 shows the top projection of 3-D confocal
images of glycocalyx (stained green with wheat germ
agglutinin) in stratified human corneal epithelial cells.
As shown in Figure 4, treatment of corneal epithe-
lial cells with IL-6, TNF-α, and IFN-γ (250 pg/mL)
did not cause any detrimental effect on corneal epithe-
lial cells glycocalyx. Digital quantification of randomly
captured images revealed an average stained area of 92
± 6% in control corneal epithelial cells, 93 ± 8% in IL-
6 treated corneal epithelial cells, 90 ± 10% in TNF-α
treated corneal epithelial cells, and 92 ± 9% in IFN-γ
treated stratified human corneal epithelial cells.
Figure 5 shows the top projection of 3-D confocal
images of glycocalyx (stained green with wheat germ
agglutinin) in stratified human conjunctival epithelial
cells. As was seen with the corneal epithelial cells, treat-
ment with IL-6, TNF-α, and IFN-γ (250 pg/mL) did
not cause any detrimental effect on conjunctival epithe-
lial cells glycocalyx. Digital quantification of randomly
captured images revealed an average stained area of 80
± 11% in control corneal epithelial cells, 79 ± 8% in
IL-6 treated corneal epithelial cells, 81 ± 10% in TNF-
α treated corneal epithelial cells, and 77± 9% in IFN-γ
treated conjunctival epithelial cells.
Effect of IL-6, TNF-α, and IFN-γ on Stratified
Human Corneal and Conjunctival Epithelial
Cell Necrosis, Apoptosis, and Morphology
Loss of epithelial cell viability can compromise
ocular surface health and perpetuate inflammation.
Therefore, we next tested the effect of IL-6, TNF-
α, and IFN-γ on human corneal and conjunctival
epithelial cell necrosis and apoptosis by flowcytome-
try (scatter plot, Supplementary Fig.). None of the
cytokines caused any significant increase in apoptotic
cell death of human corneal epithelial cells (Fig. 6A).
Interestingly, IL-6 treatment (250 pg/mL) caused an
increase in necrotic cell death (see Fig. 6A). Like
the effect observed in human corneal epithelial cells,
none of the tested cytokines caused any increase in
apoptotic cell death of human conjunctival epithelial
cells (Fig. 6B). In contrast to human corneal epithe-
lial cells, TNF-α instead of IL-6 caused an increase in
Figure 4. Representative confocal Z-stack images showing glycocalyx staining in stratified cultures of human corneal epithelial cells
exposed to IL-6, TNF-α, and IFN-γ (250 pg/mL) for 24 hours. Nuclei are stained bluewith DAPI and glycocalyx is stained greenwith Alexa-488
conjugated wheat germ agglutinin lectin. Scale bar = 100 μm.
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Figure 5. Representative confocal Z-stack images showing glycocalyx staining in stratified cultures of human conjunctival epithelial cells
exposed to IL-6, TNF-α, and IFN-γ (250 pg/mL) for 24 hours. Nuclei are stained bluewith DAPI and glycocalyx is stained greenwith Alexa-488
conjugated wheat germ agglutinin lectin. Scale bar = 100 μm.
the necrotic cell death of human conjunctival epithe-
lial cells. However, none of the three tested cytokines
caused any apparent change in morphology of corneal
or conjunctival epithelial cells or no visible decrease in
cell density was observed suggesting that the cytokines
did not cause any stress, toxicity, or transdifferentiation
(Fig. 7).
Discussion
Cytokines play an important role in the initia-
tion and perpetuation of dry eye disease.10–14,30,31
Exposing ocular surface epithelial cells to hyperos-
molar stress causes the release of proinflammatory
cytokines.15,16 The level of these proinflammatory
cytokines is also significantly increased in the tears of
patients with dry eye and the conjunctiva of patients
with dry eye with Sjogren’s syndrome.17,31,32 An inverse
correlation has been demonstrated between the levels
of these cytokines and the fluorescein staining, and
goblet cell density.32 Further, topical cyclosporine, a
potent immunosuppressant that reduces proinflamma-
tory cytokines, has been shown to modulate ocular
surface mucins and increase goblet cell density.33,34
The apical surface of corneal and conjuncti-
val epithelial cells is covered with glycocalyx.1–7
Membrane-tethered mucins are important compo-
nents of glycocalyx.1–7 Multiple studies have shown
that proinflammatory cytokines can modulate the
expression of membrane-tetheredmucins in oral, nasal,
and respiratory mucosal epithelium.35–38 The results of
the present study demonstrate that IL-6, TNF-α, and
IFN-γ increase the expression of MUC1 andMUC4 in
the corneal epithelial cells at the picogram levels. Inter-
estingly, our data demonstrates that these cytokines
do not affect the MUC1 and MUC4 expression in
conjunctival epithelial cells. Although both corneal and
conjunctival epithelial cells are reported to express the
receptors for these cytokines,39–41 the differential effect
of these cytokines on MUC1 and MUC4 gene expres-
sion in corneal and conjunctival epithelial cells may
be due to differences in the receptor density, presence
of decoy molecules, differential activation of signal-
ing pathways, or different response of mucin promot-
ers in the two epithelial cell types. Multiple studies
have demonstrated that MUC1 has anti-inflammatory
properties due to the negative regulation of Toll-
like receptors.42,43 Studies have also demonstrated
that MUC1 can act as microbial scavenger to limit
Campylobacter jejuni and Helicobacter pylori infec-
tion in gastrointestinal tract in mouse model and limit
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Figure 6. Flow cytometry quantification of apoptosis and necrosis in stratified human corneal (A) and conjunctival (B) epithelial cells treat-
ment with IL-6, TNF-α, and IFN-γ (250 pg/mL) for 24 hours. The cells were stained with annexin V/propidium iodide dual staining for flow
cytometry quantification. *P < 0.05 as compared to control cells that were not exposed to any cytokine.
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Figure 7. Representative phase contrast microscopy images of stratified human corneal (A) and conjunctival (B) epithelial cells exposed
to IL-6, TNF-α, and IFN-γ (250 pg/mL) for 24 hours. Scale bar = 100 μm.
S. pneumoniae infection in epithelial cells.44–46 There-
fore, the cytokine-mediated increase in gene expression
of corneal epithelial MUC1 and MUC4 could possi-
bly represent a physiological response to enhance the
ocular surface defense against microbial stress. Inter-
estingly, these cytokines caused a significant decrease
in the expression of MUC16 in both corneal as
well as conjunctival epithelial cells. MUC16 is the
largest mucin. It has been shown to be linked to
actin cytoskeleton thus providing an adhesive function
to glycocalyx and a strong barrier function due to
its large size and glycosylation.2–6,47–49 MUC16 has
also been shown to provide lubrication and regulate
innate immune response on ocular surface.2–6,47–49
These MUC16 functions are critical for ocular surface
health.2–6,47–49 Therefore, our data raises the possibil-
ity that cytokine-mediated decrease in MUC16 may
partially contribute to ocular surface damage in condi-
tions associated with ocular surface inflammation and
elevated levels of proinflammatory cytokines.
Cytokines have also been shown to induce the
expression of enzymes, such as heparanase and
hyaluronidase, which can damage the mucin side
chains, thus compromising the integrity of glycoca-
lyx.22,23 TNF-α has been shown to induce endothe-
lial glycocalyx shedding resulting in increased vascu-
lar permeability and aberrant vasodilation.50 However,
results of the present study demonstrate that IL-6,
TNF-α, and IFN-γ do not have any detrimental effect
on corneal and conjunctival epithelial cell glycocalyx.
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Absence of shear stress and blinking effect is a limita-
tion of in vitro stratified epithelia. Thus, it will be
worthwhile to further investigate the effect of cytokines
on glycocalyx in an in vivo model. Last, none of the
cytokines caused an increased in apoptotic cell death,
but a small increase in necrotic cell death was noted
with TNF-α in conjunctival epithelial cells and with
IL-6 treatment in corneal epithelial cells. However,
no overt change in morphology or cell density was
noted. A difference in receptor density or death signal-
ing pathways activated by TNF-α or IL-6 in the two
cell lines may underlie this differential response of
corneal and conjunctival epithelial cells to these two
cytokines.
In summary, the results of the present study demon-
strate that IL-6, TNF-α, and IFN-γ have differen-
tial effects on corneal and conjunctival epithelial cells
mucins expression and cause an increase in MUC1
and MUC4 gene expression only in corneal epithelial
cells but cause a decrease in MUC16. Furthermore,
these cytokines did not cause any notable change in the
corneal and conjunctival glycocalyx and apoptotic cell
death.
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